Holds one active US DMF and 2 valid CEPs for lisinopril, filing since 2000. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 30 markets.
Holds one active US DMF and 2 valid CEPs for lisinopril, filing since 2000. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 30 markets.
Holds 4 active US DMFs for lisinopril, filing since 2003. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Holds one active US DMF for lisinopril, filing since 2025. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 4 markets.
Holds one active US DMF for lisinopril, filing since 2004. Its GMP is recognised in 5 markets.
Holds one valid CEP for lisinopril, filing since 2025. Its GMP is recognised in 1 market.
This page filters the worldwide Lisinopril manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Ask Fred which manufacturers are on record for lisinopril and what filings they hold.
Chat with Fred, your AI analyst